Brief: Axim Biotechnologies Inc Develops Next Generation Of Its Rapid Neutralizing Antibody Test For Covid-19
12/10/2021 14:24
Oct 12 (Reuters) - Axim Biotechnologies Inc AXIM.PK :
* AXIM® BIOTECHNOLOGIES DEVELOPS NEXT GENERATION OF ITS
RAPID
NEUTRALIZING ANTIBODY TEST FOR COVID-19
Source text for Eikon: ID:nGNX6nXJ4L
Further company coverage: AXIM.PK
Recent news on Axim Biotechnologies
See all newsBrief: AXIM Biotechnologies Partners With Arizona State University To Determine Antibody Levels Against Covid-19
Brief: Axim Biotechnologies Inc Develops Next Generation Of Its Rapid Neutralizing Antibody Test For Covid-19
Brief: AXIM Biotechnologies To Acquire Technology Including
Brief: Axim® Biotechnologies Successfully Completes Point-Of-Care Clinical Trials On Its Rapid Covid-19 Neutralizing Antibody Test
Brief: Axim Biotechnologies Inc Says Filed A Provisional Patent For A First-In-Class Face Mask That Captures And Deactivates Sars-Cov-2